Healthcare provider profile · identity verified

Ruben D Adriano, M.D.

Internal Medicine · LAKELAND, FL · NPI 1801890462

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	712	217
Levothyroxine Sodium	Levothyroxine Sodium	467	126
Rosuvastatin Calcium	Rosuvastatin Calcium	434	121
Amlodipine Besylate	Amlodipine Besylate	405	123
Losartan Potassium	Losartan Potassium	389	112
Metformin Hcl	Metformin Hcl	354	95
Gabapentin	Gabapentin	308	91
Metoprolol Succinate	Metoprolol Succinate	285	82
Pantoprazole Sodium	Pantoprazole Sodium	253	74
Lisinopril	Lisinopril	243	69
Montelukast Sodium	Montelukast Sodium	242	75
Carvedilol	Carvedilol	235	75
Pravastatin Sodium	Pravastatin Sodium	224	57
Tamsulosin Hcl	Tamsulosin Hcl	203	62
Eliquis	Apixaban	181	38
Furosemide	Furosemide	177	56
Ozempic	Semaglutide	166	28
Metoprolol Tartrate	Metoprolol Tartrate	158	50
Tramadol Hcl	Tramadol Hcl	156	31
Clopidogrel	Clopidogrel Bisulfate	149	46
Omeprazole	Omeprazole	149	42
Potassium Chloride	Potassium Chloride	132	36
Jardiance	Empagliflozin	121	26
Ezetimibe	Ezetimibe	115	33
Fluticasone Propionate	Fluticasone Propionate	111	49
Tizanidine Hcl	Tizanidine Hcl	107	31
Alprazolam	Alprazolam	106	22
Valsartan	Valsartan	105	31
Hydrochlorothiazide	Hydrochlorothiazide	99	29
Simvastatin	Simvastatin	96	23
Albuterol Sulfate Hfa	Albuterol Sulfate	95	36
Duloxetine Hcl	Duloxetine Hcl	95	24
Allopurinol	Allopurinol	93	23
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	91	25
Irbesartan	Irbesartan	81	22
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	80	18
Escitalopram Oxalate	Escitalopram Oxalate	79	27
Spironolactone	Spironolactone	76	24
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	75	19
Donepezil Hcl	Donepezil Hcl	73	24
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	71	18
Warfarin Sodium	Warfarin Sodium	64	suppressed
Finasteride	Finasteride	62	22
Mounjaro	Tirzepatide	61	14
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	61	11
Trulicity	Dulaglutide	60	16
Glimepiride	Glimepiride	58	17
Hydralazine Hcl	Hydralazine Hcl	57	16
Lorazepam	Lorazepam	57	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	57	14
Atenolol	Atenolol	56	15
Doxycycline Hyclate	Doxycycline Hyclate	55	31
Pioglitazone Hcl	Pioglitazone Hcl	55	14
Trazodone Hcl	Trazodone Hcl	55	17
Famotidine	Famotidine	54	20
Bupropion Hcl Sr	Bupropion Hcl	51	16
Metformin Hcl Er	Metformin Hcl	50	13
Rybelsus	Semaglutide	50	14
Sertraline Hcl	Sertraline Hcl	50	17
Clonazepam	Clonazepam	49	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	49	13
Buspirone Hcl	Buspirone Hcl	46	15
Mirtazapine	Mirtazapine	46	12
Azithromycin	Azithromycin	44	37
Jantoven	Warfarin Sodium	44	suppressed
Glipizide	Glipizide	43	13
Fenofibrate	Fenofibrate	41	12
Tradjenta	Linagliptin	39	suppressed
Amoxicillin	Amoxicillin	37	20
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	37	suppressed
Glipizide Er	Glipizide	36	suppressed
Meloxicam	Meloxicam	36	11
Synthroid	Levothyroxine Sodium	35	12
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	32	suppressed
Clonidine Hcl	Clonidine Hcl	32	12
Entresto	Sacubitril/Valsartan	32	suppressed
Ropinirole Hcl	Ropinirole Hcl	32	suppressed
Farxiga	Dapagliflozin Propanediol	31	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	31	suppressed
Nitroglycerin	Nitroglycerin	31	16
Citalopram Hbr	Citalopram Hydrobromide	30	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	29	suppressed
Xarelto	Rivaroxaban	29	suppressed
Breo Ellipta	Fluticasone/Vilanterol	28	suppressed
Celecoxib	Celecoxib	28	suppressed
Nebivolol Hcl	Nebivolol Hcl	28	suppressed
Tresiba Flextouch U-200	Insulin Degludec	28	suppressed
Sildenafil Citrate	Sildenafil Citrate	27	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	26	suppressed
Prednisone	Prednisone	26	22
Pregabalin	Pregabalin	25	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	24	12
Glyxambi	Empagliflozin/Linagliptin	24	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	24	suppressed
Latanoprost	Latanoprost	23	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	22	suppressed
Digoxin	Digoxin	22	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	22	suppressed
Sucralfate	Sucralfate	22	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	22	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	21	suppressed
Bupropion Xl	Bupropion Hcl	20	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	20	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	20	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Memantine Hcl	Memantine Hcl	20	suppressed
Azelastine Hcl	Azelastine Hcl	19	suppressed
Ventolin Hfa	Albuterol Sulfate	19	suppressed
Candesartan-Hydrochlorothiazid	Candesartan/Hydrochlorothiazid	18	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	18	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	18	suppressed
Soliqua 100-33	Insulin Glargine/Lixisenatide	18	suppressed
Colesevelam Hcl	Colesevelam Hcl	17	suppressed
Repatha Sureclick	Evolocumab	17	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	17	suppressed
Testosterone	Testosterone	17	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Bumetanide	Bumetanide	16	suppressed
Telmisartan	Telmisartan	16	suppressed
Levetiracetam	Levetiracetam	15	suppressed
Paroxetine Hcl	Paroxetine Hcl	15	suppressed
Amiodarone Hcl	Amiodarone Hcl	14	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Lovastatin	Lovastatin	14	suppressed
Meclizine Hcl	Meclizine Hcl	14	suppressed
Nifedipine Er	Nifedipine	14	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Solifenacin Succinate	Solifenacin Succinate	14	suppressed
Symbicort	Budesonide/Formoterol Fumarate	14	suppressed
Ulticare Pen Needle	Pen Needle, Diabetic	14	suppressed
Breyna	Budesonide/Formoterol Fumarate	13	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	13	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	13	suppressed
Lactulose	Lactulose	13	suppressed
Metronidazole	Metronidazole	13	suppressed
Mupirocin	Mupirocin	13	suppressed
Nystatin	Nystatin	13	suppressed
Ondansetron Odt	Ondansetron	13	suppressed
Tiadylt Er	Diltiazem Hcl	13	suppressed
Verapamil Er	Verapamil Hcl	13	suppressed
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	12	suppressed
Temazepam	Temazepam	12	suppressed
Tiotropium Bromide	Tiotropium Bromide	12	suppressed
Acyclovir	Acyclovir	11	suppressed
Bydureon Bcise	Exenatide Microspheres	11	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Januvia	Sitagliptin Phosphate	11	suppressed
Levemir Flexpen	Insulin Detemir	11	suppressed
Lidocaine	Lidocaine	11	suppressed
Mesalamine Dr	Mesalamine	11	suppressed
Rivastigmine	Rivastigmine Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error